DataMeds AI MEDS Income Statement (2023-2026)

NASDAQ MEDS
$1.45 +0.02 (+1.40%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter) 0.04M5.67M12.41M10.86M7.79M3.01M1.67M1.56M
Cost of Revenue (Quarter) 0.05M5.15M11.16M10.17M7.29M2.78M9.53M1.39M
Gross Profit (Quarter) -0.00M0.52M1.25M0.69M0.51M0.23M-7.86M0.17M
Operating items
Research & Development (Quarter) 0.07M0.34M0.80M0.01M0.96M
Selling, General & Administrative (Quarter) 0.08M0.57M1.80M4.35M31.17M4.86M30.17M4.13M4.87M
Other Operating Expenses (Quarter) 0.47M0.65M0.80M0.80M0.80M13.36M0.36M
Operating Expenses (Quarter) 0.08M0.57M2.27M5.00M32.04M6.01M31.78M17.50M6.19M
Operating Income (Quarter) -0.08M-0.57M-1.74M-3.75M-31.35M-5.50M-31.55M-25.35M-6.02M
EBIT (Quarter) -0.08M-0.57M-1.74M-3.75M-31.35M-5.50M-31.55M-25.35M-6.02M
Non-operating items
Other Non Operating Income (Quarter) 0.02M0.10M0.01M0.01M0.01M1.40M0.26M
Non Operating Income (Quarter) -0.00M-0.00M-0.12M-0.58M-1.08M-1.17M-2.77M-2.50M-1.73M
Net income details
EBT (Quarter) -0.08M-0.57M-1.87M-4.33M-32.43M-6.67M-34.32M-27.85M-7.74M
Profit After Tax (Quarter) -0.08M-0.57M-1.87M-4.33M-32.43M-6.67M-34.32M-27.85M-7.74M
Income from Continuing Operations (Quarter) -0.08M-0.57M-1.87M-4.33M-32.43M-6.67M-34.32M-27.85M-7.74M
Consolidated Net Income (Quarter) -0.08M-0.57M-1.87M-4.33M-32.43M-6.67M-34.32M-27.85M-7.74M
Income towards Parent Company (Quarter) -0.08M-0.57M-1.87M-4.33M-32.43M-6.67M-34.32M-27.85M-7.74M
Net Income towards Common Stockholders (Quarter) -0.08M-0.57M-1.87M-4.33M-32.43M-6.67M-34.32M-27.85M-7.74M
Additional items
EPS (Basic) (Quarter) -0.09-0.63-1.93-4.58-31.23-5.40-23.07-19.62-3.70
EPS (Diluted) (Quarter) -0.09-0.63-1.93-4.58-31.23-5.40-23.07-19.62-3.70
Shares Outstanding (Quarter) 0.89M0.89M0.92M0.97M0.95M1.04M1.24M1.49M1.42M2.09M2.09M
Shares Outstanding (Diluted) (Quarter) 0.89M0.89M0.92M0.97M0.95M1.04M1.24M1.49M1.42M2.09M2.09M
Shares Outstanding (Entity) (Quarter) 0.89M0.89M0.94M1.02M1.02M1.23M1.26M1.49M1.42M2.39M
EBITDA (Quarter) -0.08M-0.57M-1.74M-3.75M-31.35M-5.50M-31.55M-25.35M-6.02M
Interest Expenses (Quarter) 0.74M0.00M0.00M0.14M0.19M1.49M1.36M1.43M0.88M-2.27M-8.82M